Ohio Dermatological Association
  • Home
  • About
    • About the ODA
    • Membership
    • People
    • About the ODF
  • Advocacy
    • Advocacy Updates
    • Advocacy Document Library
  • Annual Meeting
    • Information and Registration
    • Annual Meeting Exhibitor Information
  • News
  • Contact us
Select Page

SB 347 – Support Letter

by Charles L. Heaton, MD | Aug 27, 2012

  • Version
  • Download 19
  • File Size 89.46 KB
  • Create Date August 27, 2012
  • Download

Recent Posts

  • ODA Guide: Terminal Distributor of Dangerous Drugs (TDDD) License Refresher and FAQ
  • Health Advisory: Adverse Effects Linked To Counterfeit Or Mishandled Botulinum Toxin Injections
  • ODA to host annual advocacy day – May 22, 2024
  • MRSA found in wrestlers at high school in Toledo area with bacterial sensitivities making it easy to treat
  • ODA Shade Structure Initiative – “Camp is Good Medicine”

Archives

  • June 2024
  • April 2024
  • March 2024
  • February 2024
  • June 2023
  • February 2023
  • June 2022
  • May 2022
  • April 2022
  • December 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • December 2020
  • August 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • May 2019
  • March 2019
  • February 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • November 2017
  • June 2017
  • Facebook
  • Twitter
  • LinkedIn

Copyright © 2024 Ohio Dermatological Association